4 Einträge gefunden

1. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

   1. Saraceni, Francesco
   2. Labopin, Myriam
   3. Forcade, Edouard
   4. Kröger, Nicolaus
   5. Socié, Gerard
   6. Niittyvuopio, Riitta
   7. Cornelissen, Jan J

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission:on behalf of the ALWP of the EBMT

   1. Shem-Tov, Noga
   2. Peczynski, Christophe
   3. Labopin, Myriam
   4. Itälä-Remes, Maija
   5. Blaise, Didier
   6. Labussière-Wallet, Hélène
   7. Socié, Gerard

   2020 - Forschungsinformationssystem des UKE
3. Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

   1. Nagler, Arnon
   2. Labopin, Myriam
   3. Canaani, Jonathan
   4. Niittyvuopio, Riitta
   5. Socié, Gerard
   6. Kröger, Nicolaus
   7. Itäla-Remes, Maija

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
4. Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

   1. Saraceni, Francesco
   2. Labopin, Myriam
   3. Brecht, Arne
   4. Kröger, Nicolaus
   5. Eder, Matthias
   6. Tischer, Johanna
   7. Labussière-Wallet, Hélène

   2019 - Forschungsinformationssystem des UKE - frei zugänglich